Skip to main content

Table 2 Laboratory values

From: Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis

Tests

Reference

Median

Range

HR

p value

HCT (%)

41–53

37.80

30.70 – 44.6

1.03

0.73

Hgb (g/dL)

13.5–17.5

13.20

10.40 – 15.5

1.14

0.59

Bilt (mg/dL)

0–1

0.65

0.20 – 14.6

1.31

0.02*

SGOT (mg/dL)

10–40

37.50

17 – 97

0.99

0.79

SGPT (mg/dL)

10–55

28.50

12 – 121

0.98

0.21

AP (U/L)

45–115

111.50

58 – 434

1

0.93

GLU (mg/dL)

70–110

114

69 – 247

0.99

0.88

BUN (mg/dL)

8–25

13.50

8 – 25

0.96

0.51

Cr (mg/dL)

0.60–1.50

0.80

0.50 – 1.90

0.49

0.42

LDH (U/L)

110–210

196.50

69 – 1116

0.99

0.07

CA19-9 (U/mL)

37

360

11 – 38000

1

0.28

log CA19-9 (U/mL)

-

2.55

1.04 – 4.57

1.32

0.04*

log CA19-9 dif (U/mL)

-

5.81

1.38 – 10.50

1.15

0.34

  1. HCT = hematocrit; Hgb = hemoglobin; Bilt = total bilirubin; SGOT = aspartate transaminase; SGPT = alanine transaminase; AP = Alkaline Phosphatase; GLU = glucose; BUN = Blood Urea Nitrogen; Cr = creatinine; LDH = Lactic dehydrogenase; CA19-9 = tumor marker; log CA19-9 = logarithm of CA19-9; log CA19-9 dif = difference between the logarithm of pre- and post-therapy CA19-9 levels. HR = Hazard ratio for Overall Survival after univariate analysis. P value = level of significance.